Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com Related Posts How to Invest in Medical Device Stocks and ETFs September 10, 2025 Gold and Silver Stocks Dominate TSX30 List of Top Performers September 10, 2025 Jaime Carrasco: Gold, Silver, Miners — Where to Focus in Monetary Storm September 10, 2025